박병배
2018-03-15T07:18:00Z
2018-03-15T07:18:00Z
2014-06
Blood Research, 권: 49, 호: 2, 페이지: 127-129
2287-979X
https://www.synapse.koreamed.org/search.php?where=aview&id=10.5045/br.2014.49.2.127&code=3072BR&vmode=FULL
http://hdl.handle.net/20.500.11754/47329
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by over-production of myeloid white blood cells. Philadelphia chromosome is an essential finding for CML diagnosis. Generally, a clinical diagnosis of essential thrombocythemia (ET) can be established from isolated marked thrombocytosis in peripheral blood. However, Philadelphia chromosome-positivity or bcr/abl rearrangement with isolated thrombocy-tosis should be diagnosed as CML, not ET, according to World Health Organization diag-nostic criteria. Therefore, CML should not be excluded before confirming the presence of the Philadelphia chromosome or bcr/abl rearrangement in cases of isolated thrombocy-tosis in peripheral blood. We report a case of CML with clinical features of ET in a patient successfully treated with imatinib.
en
대한혈액학회
Chronic myeloid leukemia
Philadelphia chromosome
Essential thrombocythemia
A case of chronic myeloid leukemia with features of essential thrombocythemia in peripheral blood and bone marrow
Article
2
49
10.5045/br.2014.49.2.127
127-129
Blood Research
Byun, Young-Jae
Park, Byeong-Bae
Lee, Eun-Sung
Choi, Kyung-Soo
Lee, Dae-Sung
2014041268
S
COLLEGE OF MEDICINE[S]
DEPARTMENT OF MEDICINE
bbpark